Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Angion Biomedica Corp (NQ: ANGN )

1.030 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 12, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 33,820
Open 1.010
Bid (Size) 1.020 (10)
Ask (Size) 1.080 (250)
Prev. Close 1.030
Today's Range 1.010 - 1.070
52wk Range 0.9821 - 13.66
Shares Outstanding 29,798,399
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Angion Announces Process to Explore Strategic Alternatives for Enhancing and Preserving Shareholder Value
From Angion Biomedica Corp.
Via Globe NewsWire

Performance

YTD
-64.73%
-64.73%
1 Month
-4.63%
-4.63%
3 Month
-20.77%
-20.77%
6 Month
-51.87%
-51.87%
1 Year
-90.70%
-90.70%

More News

Read More
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
HC Wainwright Downgrades Angion Biomedica
Via Benzinga
Angion Biomedica Pulls The Plug On Another Kidney Disease Trial - Read Why
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Via Benzinga
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
Via Benzinga
Nasdaq Down 100 Points; Angion Biomedica Shares Plummet
Via Benzinga
Dow Drops 250 Points; Rapid Micro Biosystems Shares Spike Higher
Via Benzinga
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2022
Via Benzinga
The Daily Biotech Pulse: Pfizer/BioNTech Ink New COVID-19 Vaccine Supply Pact, Sanofi Hit By FDA Clinical Hold, Angion Biomedica Halts Second Kidney Disease Trial
Via Benzinga
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
Via Benzinga
Angion Biomedica's Return On Capital Employed Overview
Via Benzinga
79 Biggest Movers From Yesterday
Via Benzinga
Angion Biomedica: Q1 Earnings Insights
Via Benzinga
77 Biggest Movers From Yesterday
Via Benzinga
Angion Biomedica Is 'Better Positioned' Than Peers Despite Trial Failure, HC Wainwright Thinks So
Via Benzinga
Angion Biomedica's Return On Capital Employed Insights
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
52 Biggest Movers From Friday
Via Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Partner For Shingles Vaccine, Annexon Huntington Disease Study Disappoints, Amneal Buys Neurology Assets
Via Benzinga
63 Biggest Movers From Yesterday
Via Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
50 Biggest Movers From Friday
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.